UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial

Hepatology (Baltimore, Md.), 2015-08, Vol.62 (2), p.567-574

2015

Volltextzugriff (PDF)

Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms

Diabetes and Metabolism Journal, 2019, 43(5), 175, pp.700-710

2019

Volltextzugriff (PDF)

Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients

The Eurasian Journal of Medicine, 2022-06, Vol.54 (2), p.113-120

2022

Volltextzugriff (PDF)

Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C

Human immunology, 2010-10, Vol.71 (10), p.999-1004

2010

Volltextzugriff (PDF)

Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease

Journal of diabetes and metabolic disorders, 2020-12, Vol.19 (2), p.883-894

2020

Volltextzugriff (PDF)

Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases

Hepatology (Baltimore, Md.), 2005-10, Vol.42 (4), p.838-845

2005

Volltextzugriff (PDF)

Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms

Diabetes & metabolism journal, 2019-10, Vol.43 (5), p.700

2019

Volltextzugriff (PDF)

Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study

Alcoholism, clinical and experimental research, 2013-06, Vol.37 (6), p.891-895

2013

Volltextzugriff (PDF)

Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases

Journal of gastroenterology and hepatology, 2011-02, Vol.26 (2), p.328-333

2011

Volltextzugriff (PDF)

Fibrosis P rogression in HCV C arriers with M ild H epatitis W ho P ossess the H igh‐ R epetition V ariant of the DRD 4 G ene, a G enetic M arker for B inge‐ D rinking and R isk‐ S eeking B ehavior: A L ongitudinal S tudy

Alcoholism, clinical and experimental research, 2013-06, Vol.37 (6), p.891-895

2013

Volltextzugriff (PDF)

The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases

Journal of medical virology, 2012-05, Vol.84 (5), p.747-755

2012

Volltextzugriff (PDF)

Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting

European journal of gastroenterology & hepatology, 2014-01, Vol.26 (1), p.52-58

2014

Volltextzugriff (PDF)

Liver stiffness, a non-invasive marker of liver disease: a core study group report

Antiviral therapy, 2010-01, Vol.15 Suppl 3 (3_suppl), p.69-78

2010

Volltextzugriff (PDF)

Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C

Journal of clinical gastroenterology, 2008-02, Vol.42 (2), p.219-220

2008

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2006-02, Vol.43 (2), p.375-376

2006

Volltextzugriff (PDF)

Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy : Are they really cured?

The American journal of gastroenterology, 2006-08, Vol.101 (8), p.1811-1816

2006

Volltextzugriff (PDF)

Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: The role of AST to the platelet ratio index

Clinical biochemistry, 2006-04, Vol.39 (4), p.339-343

2006

Volltextzugriff (PDF)

Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C

Clinical chemistry and laboratory medicine, 2008-01, Vol.46 (2), p.253-259

2008

Volltextzugriff (PDF)

A randomized 4-arm multicenter study of interferon alfa–2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone

Hepatology (Baltimore, Md.), 2001-07, Vol.34 (1), p.133-138

2001

Volltextzugriff (PDF)

Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis

Digestive diseases and sciences, 1989-10, Vol.34 (10), p.1559-1563

1989

Volltextzugriff (PDF)

Treatment with interferon-α2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study

European journal of gastroenterology & hepatology, 2001-02, Vol.13 (2), p.149-155

2001

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(21)

Sprache

Englisch
(20)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial

Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms

Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients

Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C

Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease

Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases

Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms

Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study

Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases

Fibrosis P rogression in HCV C arriers with M ild H epatitis W ho P ossess the H igh‐ R epetition V ariant of the DRD 4 G ene, a G enetic M arker for B inge‐ D rinking and R isk‐ S eeking B ehavior: A L ongitudinal S tudy

The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases

Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting

Liver stiffness, a non-invasive marker of liver disease: a core study group report

Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C

Reply

Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy : Are they really cured?

Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: The role of AST to the platelet ratio index

Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C

A randomized 4-arm multicenter study of interferon alfa–2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone

Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis

Treatment with interferon-α2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study

Suchergebnisse filtern